{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:51:23Z","timestamp":1793163083433,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":149,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005053","name":"CIBER-BBN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Government of Spain Ministry of Education Culture and Sports","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Government of Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"ERDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.msec.2021.112024","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T23:35:29Z","timestamp":1615419329000},"page":"112024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways"],"prefix":"10.1016","volume":"124","author":[{"given":"Eva","family":"Espinosa-Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Huerta-Madro\u00f1al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"C\u00e1mara-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Seras-Franzoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Simo","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibane","family":"Abasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"San Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2021.112024_bb0005","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"10.1016\/j.msec.2021.112024_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066128","article-title":"Targeted drug delivery systems mediated by a novel peptide in breast cancer therapy and imaging","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0015","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.msec.2021.112024_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/1574888X14666190628104721","article-title":"Novel therapeutics against breast Cancer stem cells by targeting surface markers and signaling pathways","volume":"14","author":"Das","year":"2019","journal-title":"Current stem cell research & therapy"},{"key":"10.1016\/j.msec.2021.112024_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.21037\/sci.2017.11.03","article-title":"Breast cancer stem cells-from origins to targeted therapy","volume":"4","author":"Sin","year":"2017","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.msec.2021.112024_bb0030","doi-asserted-by":"crossref","unstructured":"McCubrey, J. A.; Rakus, D.; Gizak, A.; Steelman, L. S.; Abrams, S. L.; Lertpiriyapong, K.; Fitzgerald, T. L.; Yang, L. V.; Montalto, G.; Cervello, M.; Libra, M.; Nicoletti, F.; Scalisi, A.; Torino, F.; Fenga, C.; Neri, L. M.; Marmiroli, S.; Cocco, L.; Martelli, A. M., Effects of mutations in Wnt\/\u03b2-catenin, Hedgehog, Notch and PI3K Pathways on GSK-3 Activity\u2014Diverse Effects on Cell Growth, Metabolism and Cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016, 1863, (12), 2942\u20132976.","DOI":"10.1016\/j.bbamcr.2016.09.004"},{"key":"10.1016\/j.msec.2021.112024_bb0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2018.00745","article-title":"Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-catenin pathway in chronic inflammation and oxidative stress during carcinogenesis","volume":"9","author":"Vall\u00e9e","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-6-29","article-title":"Cancer cell: using inflammation to invade the host","volume":"6","author":"Arias","year":"2007","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.msec.2021.112024_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.msec.2021.112024_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bpa.2013.10.008","article-title":"Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches","volume":"27","author":"Le","year":"2013","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrclinonc.2012.137","article-title":"Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms","volume":"9","author":"Chia","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mco.2014.446","article-title":"Potency of non-steroidal anti-inflammatory drugs in chemotherapy","volume":"3","author":"Hilovska","year":"2015","journal-title":"Molecular and clinical oncology"},{"issue":"9","key":"10.1016\/j.msec.2021.112024_bb0065","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1007\/s00044-014-0979-z","article-title":"Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention","volume":"23","author":"Aboul-Fadl","year":"2014","journal-title":"Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents"},{"issue":"2","key":"10.1016\/j.msec.2021.112024_bb0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/1940-6207.CAPR-13-0288","article-title":"Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer prevention research (Philadelphia, Pa.)"},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/1471-2407-14-567","article-title":"A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells","volume":"14","author":"Deb","year":"2014","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.msec.2021.112024_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000452315","article-title":"The role of NSAIDs in breast Cancer prevention and relapse: current evidence and future perspectives","volume":"11","author":"Moris","year":"2016","journal-title":"Breast care (Basel, Switzerland)"},{"key":"10.1016\/j.msec.2021.112024_bb0085","doi-asserted-by":"crossref","unstructured":"Wong, R., Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Advances in Pharmacological Sciences 2019, 2019, 3418975.","DOI":"10.1155\/2019\/3418975"},{"issue":"2","key":"10.1016\/j.msec.2021.112024_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/14756366.2012.762645","article-title":"Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3","volume":"29","author":"Motawi","year":"2014","journal-title":"Journal of enzyme inhibition and medicinal chemistry"},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0095","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/cas.13028","article-title":"Glycogen synthase kinase-3\u03b2 is a pivotal mediator of cancer invasion and resistance to therapy","volume":"107","author":"Domoto","year":"2016","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin. Med. Res."},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin Transl Med"},{"issue":"30","key":"10.1016\/j.msec.2021.112024_bb0110","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1039\/C7NR01582H","article-title":"Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells","volume":"9","author":"Alves Rico","year":"2017","journal-title":"Nanoscale"},{"issue":"44","key":"10.1016\/j.msec.2021.112024_bb0115","doi-asserted-by":"crossref","first-page":"17867","DOI":"10.1039\/C6DT03811E","article-title":"The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles","volume":"45","author":"Eskandari","year":"2016","journal-title":"Dalton Trans."},{"issue":"7","key":"10.1016\/j.msec.2021.112024_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000002","article-title":"Polymeric nanoparticles that combine dexamethasone and naproxen for the synergistic inhibition of Il12b transcription in macrophages","volume":"20","author":"Espinosa-Cano","year":"2020","journal-title":"Macromol. Biosci."},{"issue":"1-2","key":"10.1016\/j.msec.2021.112024_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2012.01.051","article-title":"Hemocompatibility of poly(\u025b-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan","volume":"426","author":"Bender","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.msec.2021.112024_bb0130","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1021\/acs.molpharmaceut.8b00292","article-title":"Bioinspired shielding strategies for nanoparticle drug delivery applications","volume":"15","author":"Gulati","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.msec.2021.112024_bb0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.1157","article-title":"Recent advances in stealth coating of nanoparticle drug delivery systems","volume":"4","author":"Amoozgar","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.msec.2021.112024_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050867","article-title":"Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NF\u03baB with a novel cis-element","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2021.112024_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/adhm.201601012","article-title":"The CD44-mediated uptake of hyaluronic acid-based carriers in macrophages","volume":"6","author":"Rios de la Rosa","year":"2017","journal-title":"Adv Healthc Mater"},{"issue":"7-8","key":"10.1016\/j.msec.2021.112024_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","article-title":"Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine","volume":"23","author":"Mattheolabakis","year":"2015","journal-title":"J. Drug Target."},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0155","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/polym10101133","article-title":"Hyaluronic acid-based nanomaterials for cancer therapy","volume":"10","author":"Kim","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.msec.2021.112024_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/pharmaceutics12100931","article-title":"Hyaluronic acid nanoparticles as nanomedicine for treatment of inflammatory diseases","volume":"12","author":"Rao","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0165","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1021\/am404946v","article-title":"Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles","volume":"6","author":"El-Dakdouki","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2021.112024_bb0170","doi-asserted-by":"crossref","unstructured":"Yang, C.; He, Y.; Zhang, H.; Liu, Y.; Wang, W.; Du, Y.; Gao, F., Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo. Oncotarget 2015, 6, (17), 15283\u201396.","DOI":"10.18632\/oncotarget.3681"},{"issue":"6","key":"10.1016\/j.msec.2021.112024_bb0175","first-page":"2425","article-title":"Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer","volume":"33","author":"Vangara","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.msec.2021.112024_bb0180","series-title":"ASTM E2524-08, Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles In International A. Ed. West Conshohocken, PA","year":"2008"},{"key":"10.1016\/j.msec.2021.112024_bb0185","series-title":"NCL Method ITA-12. In 2.0b ed","author":"Neun","year":"2020"},{"key":"10.1016\/j.msec.2021.112024_bb0190","series-title":"NCL Method ITA-12","author":"Cedrone","year":"2020"},{"key":"10.1016\/j.msec.2021.112024_bb0195","series-title":"NCL Method ITA-12","author":"Neun","year":"2020"},{"issue":"8","key":"10.1016\/j.msec.2021.112024_bb0200","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.nano.2015.07.009","article-title":"Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells","volume":"11","author":"Gener","year":"2015","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.msec.2021.112024_bb0205","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.msec.2021.112024_bb0210","doi-asserted-by":"crossref","DOI":"10.1177\/2041731417726464","article-title":"Crosslinking method of hyaluronic-based hydrogel for biomedical applications","volume":"8","author":"Khunmanee","year":"2017","journal-title":"J Tissue Eng"},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0215","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1021\/acs.biomac.9b01098","article-title":"Anti-inflammatory surface coatings based on polyelectrolyte multilayers of heparin and polycationic nanoparticles of naproxen-bearing polymeric drugs","volume":"20","author":"Al-Khoury","year":"2019","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.msec.2021.112024_bb0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"issue":"14","key":"10.1016\/j.msec.2021.112024_bb0225","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/adhm.201600219","article-title":"Design advances in particulate systems for biomedical applications","volume":"5","author":"Lima","year":"2016","journal-title":"Advanced Healthcare Materials"},{"issue":"34","key":"10.1016\/j.msec.2021.112024_bb0230","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1021\/acs.langmuir.5b01857","article-title":"Effects of ionic strength on the colloidal stability and interfacial assembly of hydrophobic ethyl cellulose nanoparticles","volume":"31","author":"Bizmark","year":"2015","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0235","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00396-012-2604-3","article-title":"Effects of ionic strength on the size and compactness of chitosan nanoparticles","volume":"290","author":"Jonassen","year":"2012","journal-title":"Colloid Polym. Sci."},{"issue":"96","key":"10.1016\/j.msec.2021.112024_bb0240","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0931","article-title":"Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles","volume":"11","author":"Pfeiffer","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.msec.2021.112024_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/ijms17071035","article-title":"Novel NSAID-derived drugs for the potential treatment of Alzheimer\u2019s disease","volume":"17","author":"Cacciatore","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msec.2021.112024_bb0250","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.2147\/IJN.S173198","article-title":"Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief","volume":"13","author":"Huang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"19","key":"10.1016\/j.msec.2021.112024_bb0255","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1021\/acsami.6b01135","article-title":"Hyaluronic acid-modified cationic lipid\u2013PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses","volume":"8","author":"Liu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2021.112024_bb0260","series-title":"NCL Method ITA-1","author":"Neun","year":"2020"},{"issue":"2-3","key":"10.1016\/j.msec.2021.112024_bb0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2009.01.015","article-title":"The role of nanoparticle size in hemocompatibility","volume":"258","author":"Mayer","year":"2009","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.msec.2021.112024_bb0270","first-page":"818","article-title":"Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2","volume":"23","author":"Park","year":"2008","journal-title":"Int. J. Oral Maxillofac. Implants"},{"key":"10.1016\/j.msec.2021.112024_bb0275","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2087204","article-title":"The importance of CD44 as a stem cell biomarker and therapeutic target in cancer","volume":"2016","author":"Thapa","year":"2016","journal-title":"Stem Cells Int."},{"issue":"7","key":"10.1016\/j.msec.2021.112024_bb0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4172\/1948-5956.1000144","article-title":"Human breast cancer stem cells have significantly higher rate of clathrin-independent and caveolin-independent endocytosis than the differentiated breast cancer cells","volume":"4","author":"Palaniyandi","year":"2012","journal-title":"Journal of cancer science & therapy"},{"key":"10.1016\/j.msec.2021.112024_bb0285","first-page":"8","article-title":"Receptor-meditated endocytosis by hyaluronic acid@superparamagnetic nanovetor for targeting of CD44-overexpressing tumor cells","volume":"6","author":"Yu","year":"2016","journal-title":"Nanomaterials (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/j.msec.2021.112024_bb0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cancers10120482","article-title":"Differing roles of hyaluronan molecular weight on cancer cell behavior and chemotherapy resistance","volume":"10","author":"Price","year":"2018","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.msec.2021.112024_bb0295","first-page":"1508","article-title":"Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture","volume":"92","author":"Boonmasawai","year":"2009","journal-title":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet"},{"issue":"10","key":"10.1016\/j.msec.2021.112024_bb0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00109-003-0479-y","article-title":"Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications","volume":"81","author":"Tarnawski","year":"2003","journal-title":"Journal of molecular medicine (Berlin, Germany)"},{"issue":"2","key":"10.1016\/j.msec.2021.112024_bb0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-4827(03)00269-6","article-title":"Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells","volume":"289","author":"Timoshenko","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.msec.2021.112024_bb0310","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.18632\/oncotarget.14145","article-title":"Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal\/triple negative breast cancer","volume":"8","author":"Kochel","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.msec.2021.112024_bb0315","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.arthro.2018.07.030","article-title":"The influence of naproxen on biological factors in leukocyte-rich platelet-rich plasma: a prospective comparative study","volume":"35","author":"Mannava","year":"2019","journal-title":"Arthroscopy"},{"issue":"2","key":"10.1016\/j.msec.2021.112024_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032368","article-title":"Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast Cancer cells","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.msec.2021.112024_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012715","article-title":"Diclofenac inhibits tumor growth in a murine model of pancreatic Cancer by modulation of VEGF levels and arginase activity","volume":"5","author":"Mayorek","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2021.112024_bb0330","doi-asserted-by":"crossref","unstructured":"Wang, D.; Dubois, R. N., Prostaglandins and cancer. Gut 2006, 55, (1), 115\u201322.","DOI":"10.1136\/gut.2004.047100"},{"issue":"5","key":"10.1016\/j.msec.2021.112024_bb0335","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.msec.2021.112024_bb0340","unstructured":"Wiktorowska-Owczarek, A.; Namieci\u0144ska, M.; Owczarek, J., The effect of ibuprofen on bFGF, VEGF Secretion and Cell Proliferation in the Presence of LPS in HMEC-1 Cells. Acta Pol Pharm 2015, 72, (5), 889\u2013894."},{"key":"10.1016\/j.msec.2021.112024_bb0345","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3906\/sag-1602-60","article-title":"Meloxicam and diclofenac do not change VEGF and PDGF-ABserum levels of platelet-rich plasma","volume":"47","author":"Utku","year":"2017","journal-title":"Turkish Journal of Medical Sciences"},{"issue":"4","key":"10.1016\/j.msec.2021.112024_bb0350","article-title":"Improving VEGF-targeted therapies through inhibition of COX-2\/PGE2 signaling","volume":"1","author":"Xu","year":"2014","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.msec.2021.112024_bb0355","doi-asserted-by":"crossref","unstructured":"Wu, D.; Pan, W., GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 2010, 35, (3), 161\u20138.","DOI":"10.1016\/j.tibs.2009.10.002"},{"issue":"11","key":"10.1016\/j.msec.2021.112024_bb0360","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/emboj\/18.11.3054","article-title":"Excess \u03b2-catenin promotes accumulation of transcriptionally active p53","volume":"18","author":"Damalas","year":"1999","journal-title":"EMBO J."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:14:09Z","timestamp":1760534049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493121001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":72,"alternative-id":["S0928493121001636"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2021.112024","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2021.112024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112024"}}